US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,737.83

+7.090.41%

Number of Gainers:2

Number of Losers:- -

Number of Flat:- -

PE:- -

High:1,755.66

Open:1,732.03

Low:1,731.68

Close:1,730.74

Volume:7.08M

Turnover:1.03B

Market Cap:447.86B

Float Cap:439.59B

Loading ...

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Novartis Halts ALS Drug Development After Phase 2 Trial Miss

MT Newswires Live

Novartis AG Rises Wednesday

Novartis to End ALS Trial Amid String of Study Failures

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Gilead announces agreement with PAHO for lenacapavir access

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS

Legend Biotech Taps Novartis Veteran Zhang as CEO

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

NYSE Order Imbalance 99880.0 Shares on Sell Side

THOMSON REUTERS

Novartis AG Rises Monday, Outperforms Market

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Novartis: More Pain on the Way?

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK4578/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1737.8278,"timestamp":1789588799999,"preClose":1730.7407,"halted":0,"volume":7081197,"delay":0,"changeRate":0.004095,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":7.087036,"latestTime":"09-16 16:00:00 EDT","open":1732.0331,"high":1755.6616,"low":1731.6823,"amount":1030857228.514593,"amplitude":0.013855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.351222,"peRate":46.833359,"turnoverRate":0.002292,"increases":2,"decrements":0,"flats":0,"marketCap":447863160832,"floatMarketCap":439585603584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1755.6616,"amplitude":0.013855,"preClose":1730.7407,"low":1731.6823,"pbRate":"8.351222","latestPrice":1737.8278,"volume":7081197,"delay":0,"open":1732.0331,"prevYearClose":1612.5378,"prevWeekClose":1707.2908,"prevMonthClose":1830.2803,"prevQuarterClose":1768.1697,"fiveDayClose":1719.0243,"twentyDayClose":1835.2719,"sixtyDayClose":1703.1655,"secType":"PLATE","market":"US","turnoverRate":0.002292,"peRate":46.833359,"marketCap":447863160832,"floatMarketCap":439585603584,"timestamp":1789588799999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":2,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","LU0823416689.USD","LU2357627491.SGD","LU0289739699.SGD","IE00BZ1G4Q59.USD","GILD","LU0859254822.USD","BIB","BK4566","IBB","LU1023059063.AUD","LU1057294990.SGD","LU1674673691.USD","IE00BKVL7J92.USD","IBBQ","LU0234570918.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","BBH","IE0002270589.USD","IE00B3T34201.USD","LU0965509101.SGD","LU1066053197.SGD","SG9999015952.SGD","BK4588","LU0965509283.SGD","MEDI","LU0114720955.EUR","SG9999015986.USD","BK4568","LU1430594728.SGD","LU2468319806.SGD","TBXU","BK4578","LU0109394709.USD","LU1066051498.USD","LU1585245621.USD","TMED","LU0882574055.USD","BK4532","BK4550","LU0320765992.SGD","SG9999015945.SGD","LU1674673428.USD","BK4585","LU1778281490.HKD","BMED","LU0122379950.USD","IE00B19Z3B42.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987836","title":"Novartis Halts ALS Drug Development After Phase 2 Trial Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987836","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987836?lang=en_us&edition=fundamental","pubTime":"2026-09-17 00:40","pubTimestamp":1789576836,"startTime":"0","endTime":"0","summary":"Novartis  discontinued development of VHB937 for amyotrophic lateral sclerosis, the company said in an emailed statement to MT Newswires Wednesday.The decision was taken after a phase 2 Astrals study did not meet its primary or secondary endpoints.The company said it remains committed to sharing the study findings and applying the learnings from the research to advance scientific understanding of neurodegenerative diseases.Price: 139.59, Change: +0.97, Percent Change: +0.70","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVS","IE00B2B36J28.USD","BK4585","LU0208291251.USD","BK4007","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","MEDX","IE00BJT1NW94.SGD","LU0070302665.USD","BK4532","IE0009355771.USD","PPH","BK4578","LU0211331839.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668824599","title":"Novartis AG Rises Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2668824599","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668824599?lang=en_us&edition=fundamental","pubTime":"2026-09-17 00:15","pubTimestamp":1789575300,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  advanced 0.4% to CHF114.28 Wednesday on what proved to be an overall positive trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.4% to 13,868.66.Novartis AG closed CHF18.40 short of its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 4,081,231, compared to the 50-day average trading volume of 2,565,450.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","IE00B2B36J28.USD","BK4585","LU0208291251.USD","BK4007","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","MEDX","IE00BJT1NW94.SGD","LU0070302665.USD","BK4532","IE0009355771.USD","PPH","BK4578","LU0211331839.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667823399","title":"Novartis to End ALS Trial Amid String of Study Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2667823399","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667823399?lang=en_us&edition=fundamental","pubTime":"2026-09-16 23:52","pubTimestamp":1789573920,"startTime":"0","endTime":"0","summary":"Novartis said its Phase 2 trial of an ALS treatment didn't meet its primary or secondary endpoints.The drugmaker said Wednesday that it has decided to discontinue the development of VHB937 in ALS.The trial's end comes after a string of setbacks for Novartis this month.Earlier in September, the Swiss company said an experimental neuromuscular treatment called del-desiran failed a late-stage clinical trial. It also said that a closely watched cholesterol drug called pelacarsen failed to reduce the risk of severe cardiovascular events.Novartis also paused eight trials of a cell therapy for autoimmune and neurological disorders in late August, after three patients died.Its shares dropped earlier this month amid the news of the failed trials, with the stock down 9% over the past 30 days.Analysts say the string of failures could reignite investors' concerns about how Novartis will grow beyond 2030.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU0070302665.USD","BK4585","BK4007","IE00BJJMRZ35.SGD","MEDX","BK4578","LU0211331839.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","NVS","IE0009355771.USD","PPH","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4588","LU0320765489.SGD","BK4532","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","LU0225283273.USD","ARTY","CHPS","IE00B3T34201.USD","LU1303367103.USD","LU0320765646.SGD","BK4575","LU2357627491.SGD","SG9999001424.SGD","LU0203347892.USD","IE00BJTD4N35.SGD","LU1150488135.SGD","LU1037948541.HKD","SKDD","SG9999015986.USD","GILD","LU2265009873.SGD","LU1150488218.USD","IE00B3S45H60.SGD","LU0942090050.USD","LU1585245621.USD","LU0070302665.USD","LU2213496289.HKD","LU0265550946.USD","LU0868494617.USD","IE00BK4W5M84.HKD","LU0109392836.USD","LU2237443622.USD","LU1548497426.USD","FAI","BK4585","SG9999015952.SGD","BK4614","LU1064131342.USD","LU0106831901.USD","IXG","HK0000304805.HKD","LU0889565916.HKD","SLVR","HYNX","AUAU","AMYY","LU2008162690.USD","LU2360106780.USD","LU0654597011.USD","IE00BJLML261.HKD","LU2860962120.EUR","IE00B1BXHZ80.USD","LU2237957811.SGD","LU1145028129.USD","BK4583","IE00BWXC8680.SGD","LU1242518931.SGD","LU0048584097.USD","LU1496350171.SGD","LU1861558580.USD","LU2023250504.SGD","AMDS","BK4232","LU0496365809.HKD","LU0251132253.USD","LU2244417387.USD","LU2357305700.SGD","LU0097036916.USD","BK4579","LU2750360997.AUD","LU0215105999.USD","LU1974910355.USD","LU0266013472.USD","LU1236620750.USD","LU0345774631.USD","QQQA","BIB","GDX","IE00BKDWB100.SGD","BK4581","BK4605","LU0056508442.USD","LU0979878070.USD","LU1116320901.HKD","LU0320765992.SGD","LU1430597077.USD","SKHY","LU0965508806.USD","LU0210536198.USD","LU1989764748.USD","SKHU","LU2054465674.USD","LU2112291526.USD","07709","LU2746668461.USD","BK4017","LU0006306889.USD","SKHQ","SAMD0main","LU0198837287.USD","LU2098885051.SGD","AMDG","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","BK4588","LU1670628061.USD","LU0612318385.USD","BK4602","LU0310799852.SGD","LU0823411888.USD","LU2250418816.HKD","IE0000B7K699.USD","LU1571399168.USD","BK4142","IE000WAW04H5.SGD","BKNU","LU2168564495.EUR","LU2236285917.USD","LU2543165471.USD","SMHX","JPO","LU1244550494.USD","LU2381873111.SGD","LU1043141123.HKD","LU2177674079.SGD","SMH","PSI","BK4567","HK0000304797.USD","LU1366192091.USD","IE0004445239.USD","LU1551013425.SGD","LU0128525929.USD","AMDC","LU2505996509.AUD","LU0077335932.USD","LU2756315664.SGD","AMD","AMDD","LEGR","BK4207","IE000SO60NU8.SGD","LU1804176565.USD","IE00B19Z3581.USD","LU0211326839.USD","LU0345769631.USD","LU2237443978.SGD","CHAT","BK4554","SIL","IE00B1XK9C88.USD","IE00B5TLWC47.USD","LU0823421416.USD","LU0823416689.USD","LU0557290698.USD","LU0211328371.USD","DAMD","LU1699723380.USD","LU1989772923.USD","LU1061106388.HKD","INTW","IE00B775SV38.USD","LU2290526834.HKD","LU0965509101.SGD","LU0426412945.USD","BK4135","LU1043141396.HKD","BMED","LU0321505868.SGD","SKHZ","LU1066053197.SGD","LU2247934214.USD","GOAU","IE00BKVL7J92.USD","LU0157215616.USD","TEK","LU2430703178.SGD","IE00BMPRXR70.SGD","LU1037948897.HKD","LU0345770308.USD","IE00B5949003.HKD","SG9999004303.SGD","LU0742534661.SGD","IE0001KFT4U8.USD","LU1244550221.USD","LU1267930490.SGD","LU2461242641.AUD","ILDR","LU2097829019.USD","IE00BK4W5L77.USD","LU2361044949.HKD","BK4504","LU0133085943.USD","LU0426417589.USD","LU0689472784.USD","SKHN","IE0034235188.USD","LU2764263039.SGD","LU0786609619.USD","IE00BSNM7G36.USD","LU0787776722.HKD","LU0082616367.USD","LU0174119429.USD","IE00BDCRKT87.USD","LU0127658192.USD","LU1116320737.USD","LU0058720904.USD","LU0417517546.SGD","INTC","LU0234570918.USD","LU0320765489.SGD","IE00BMPRXN33.USD","BK4532","AZNH","LU0256863902.USD","SKUU","IE00B7SZLL34.SGD","LU0823397285.USD","LU0868494708.USD","TMED","LU0149725797.USD","BKNG","LU2720916845.USD","LU0203345920.USD","LU0823434740.USD","LU1861559042.SGD","LU2458330243.SGD","LU2471134879.HKD","IE0009356076.USD","LU1880398471.USD","LU2750360641.GBP","FTXO","LU2168564149.EUR","DRIV","JPMO","LU2552382058.USD","LU0708994859.HKD","SKHA","LU1934455863.HKD","LU0642271901.SGD","LU2168563687.JPY","GAMR","IE00B19Z3B42.SGD","IE000BZT7R73.USD","LU2168564222.USD","GLDN","LU2237957902.USD","SINTCmain","LU2237443382.USD","LU1894683348.USD","LINT","LU2361044865.SGD","LU2106854487.HKD","LU1496350502.SGD","BK4533","AMDW","LU0965509010.AUD","IE000F7OJYX1.SGD","LU1839511570.USD","LU2471134952.CNY","XLF","LU0316494557.USD","LU1242518857.USD","AMDU","LU0211331839.USD","LU0321505439.SGD","KBWB","LU0640476718.USD","LU1121112475.USD","IE00BDRTCR15.USD","IE00BLSP4239.USD","IETC","LU0122379950.USD","BK4550","FMTL","LU0889565833.HKD","JPM","LU0251142724.SGD","LU1267930573.SGD","LU0994945656.USD","BK4007","LU2361045086.USD","FNCL","SK","XNTK","LU0390134368.USD","04335","LU2462591350.SGD","TRFK","LU1244550577.SGD","IE0034235295.USD","LU0943347566.SGD","BK4516","LU2552382132.HKD","LU2746668974.SGD","LU1084165304.USD","LU2592432038.USD","LU1989772840.SGD","IYG","BBH","LU0256863811.USD","LU0353189763.USD","LU2552382215.SGD","IE00BHPRN162.USD","LU0345770993.USD","LU2764263203.CNY","LU1551013342.USD","LU0792757196.USD","LU1934455277.USD","LU1023059063.AUD","LU1988902786.USD","LU0965509283.SGD","BK4512","LU2355687059.USD","LU2023250330.USD","BK4139","LU1956131251.USD","LU1989764664.SGD","LU0345769128.USD","LU0289739699.SGD","TROW","LU1894683264.USD","LU2471134796.USD","LU2087621335.USD","LU0048573561.USD","LU0859254822.USD","LU1430594728.SGD","BK4578","LU1316542783.SGD","BK4566","SKHL","LU0353189680.USD","BK4543","LU1829250122.USD","LU1923623000.USD","LU1720051108.HKD","AMDY","BK4520","FNV","BK4612","INT","AIQ","USXF","LU1852331112.SGD","LU2148611432.USD","LU0208291251.USD","LU2168564065.EUR","TRUF","LU0823421333.USD","IBB","LU2458330169.SGD","IE000MB6IJN5.SGD","LU1366333091.USD","LU1951200564.SGD","LU0683600562.USD","LU2324357040.USD","BK4573","LU0882574139.USD","FTXL","LU0719512351.SGD","IE00BZ1G4Q59.USD","BK4527","LU0976567544.SGD","LU0823413587.USD","LU1119994496.HKD","LU0154236417.USD","LU0310800379.SGD","LU1720051017.SGD","AWAY","LU0432979614.USD","BK4141","AMDL","LU1057294990.SGD","JBHT","LU1880398554.USD","LU1668664300.SGD","IE00BQXX3F31.USD","LU0889566641.SGD","SG9999015945.SGD","LU0823413660.USD","SOXY","SOXX","LU1861215975.USD","LU1674673428.USD","IE0002270589.USD","VFH","IE00BQXX3C00.GBP","LU0106261372.USD","IBBQ","LU2430703095.HKD","LU2764262908.HKD","TBXU","SG9999002232.USD","LU0211326755.USD","WISE","LU1670627923.USD","LU2023250843.SGD","AIS","LU2237443895.HKD","LU1066051498.USD","LU2089984988.USD","SG9999001440.SGD","LU1280957306.USD","LU2242649171.HKD","LU0238689110.USD","LU2471134523.USD","IE00BMPRXQ63.HKD","SG9999002224.SGD","LU1914381329.SGD","LU2430703251.USD","LU0882574055.USD","IE0034235303.USD","LU0964807845.USD","LU0109394709.USD","LU2211815571.USD","IE00BJTD4V19.USD","LU0234572021.USD","LU1674673691.USD","LU1934455194.USD","LU2237443465.HKD","SGXZ99366536.SGD","WUGI","LU1778281490.HKD","SKHX","LU0170899867.USD","LU2456880835.USD","BK4022","LU0820561818.USD","LU1861220033.SGD","TTEQ","IE00BFXG1179.USD","LU0187121727.USD","LU0251131958.USD","LU0323591593.USD","LU0823397103.USD","LU2108987350.USD","BK4515","LU0265550359.USD","LU0211327993.USD","IE00BQXX3D17.EUR","LU0820561909.HKD","LU1629891620.HKD","LU2505996681.GBP","TFNS","LU1261432733.SGD","WNDR","LU2931357623.SGD","SKHYV","LU2896262040.SGD","BK4548","LU1951198990.SGD","LU2264538146.SGD","LU0267386448.USD","IYF","LU2417539215.USD","UYG","SGXZ23171101.USD","LU2087625088.SGD","INYY","BAI","IE00BYXW3230.USD","LU1917777945.USD","LU2462157665.USD","SG9999015978.USD","LU2468319806.SGD","IE00BBT3K403.USD","IE000M9KFDE8.USD","LU0971096721.USD","LU1363072403.SGD","LU2756315318.SGD","LU0612318971.USD","SGXZ51526630.SGD","BK4534","LU1232071149.USD","WPM","LU0820562030.AUD","BK4535","BK4568","CNAV","LU2237443549.SGD","LU2360107168.USD","BK4529","AMUU","LU1236620834.HKD","LU2089985449.USD","AZN","LU0114720955.EUR","LU1032466523.USD","LU0823434583.USD","LU0345774391.USD","MEDI","LU1267930813.SGD","SGXZ81514606.USD","LU0861579265.USD","LU0274383776.USD","SILJ","LU0029864427.USD","LU1162221912.USD","LU1803068979.SGD","LU0081259029.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU1839511570.USD","BMED","LU2089984988.USD","BK4568","LU0114720955.EUR","LU0861579265.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BKVL7J92.USD","IBB","LU0965509283.SGD","LU1934455277.USD","LU0058720904.USD","LU1778281490.HKD","LU2468319806.SGD","LU2357627491.SGD","TBXU","LU0889565916.HKD","LU1430594728.SGD","MEDI","BK4532","BIB","LU1585245621.USD","BK4583","LU0234570918.USD","LU1674673691.USD","LU1934455863.HKD","LU1066051498.USD","LU1037948897.HKD","BK4578","LU2112291526.USD","SG9999015945.SGD","LU1066053197.SGD","LU1061106388.HKD","LU1037948541.HKD","IE00B7SZLL34.SGD","LU2087621335.USD","IBBQ","IE00BZ1G4Q59.USD","LU0122379950.USD","LU0823416689.USD","SG9999015978.USD","TMED","LU0320765992.SGD","GILD","LU0965509010.AUD","SG9999015986.USD","BK4550","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625575","title":"Gilead announces agreement with PAHO for lenacapavir access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625575","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625575?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485318,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced a new agreement with the Pan American Health Organization, or PAHO, to accelerate access to twice-yearly lenacapav...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IBB","LU0965509101.SGD","LU1778281490.HKD","LU2089984988.USD","TMED","LU1839511570.USD","LU0965509010.AUD","TBXU","MEDI","BK4550","LU1066051498.USD","BK4578","SG9999015986.USD","LU1585245621.USD","LU1430594728.SGD","LU0234570918.USD","LU1934455863.HKD","SG9999015952.SGD","LU1571399168.USD","BK4583","BK4585","GILD","LU0965509283.SGD","BK4566","LU0882574055.USD","LU1674673428.USD","BMED","LU0861579265.USD","BK4588","LU1023059063.AUD","LU1674673691.USD","LU2324357040.USD","LU1037948541.HKD","IBBQ","LU0859254822.USD","IE0002270589.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4568","LU1061106388.HKD","LU1066053197.SGD","BK4532","SG9999015945.SGD","IE00B7SZLL34.SGD","LU1037948897.HKD","BIB","LU2468319806.SGD","LU0114720955.EUR","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623063","title":"Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623063?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU1061106388.HKD","LU0965509010.AUD","LU0965509283.SGD","BK4578","IE0002270589.USD","GILD","BMED","IE00B19Z3581.USD","TMED","LU1778281490.HKD","LU1037948897.HKD","LU0234570918.USD","LU0859254822.USD","LU1839511570.USD","BK4532","IBB","IE00BKVL7J92.USD","SG9999015986.USD","IE00B3T34201.USD","MEDI","LU0058720904.USD","LU1057294990.SGD","LU0889565916.HKD","LU1066053197.SGD","LU2324357040.USD","LU1571399168.USD","LU2468319806.SGD","BBH","IBBQ","LU1674673691.USD","LU0861579265.USD","BK4566","BIB","LU0109394709.USD","LU1430594728.SGD","SG9999015952.SGD","LU1037948541.HKD","LU0823416689.USD","LU1934455277.USD","TBXU","LU1585245621.USD","LU2357627491.SGD","LU0882574055.USD","SG9999015945.SGD","SG9999015978.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","BK4583","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623061","title":"Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623061","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623061?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0859254822.USD","IE0002270589.USD","TBXU","BK4550","LU1057294990.SGD","LU1066051498.USD","SG9999015945.SGD","IBBQ","LU0965509283.SGD","LU0122379950.USD","LU1571399168.USD","LU1934455277.USD","BK4532","LU2324357040.USD","LU1934455194.USD","LU0289739699.SGD","BMED","LU1778281490.HKD","BK4566","IBB","BK4568","LU0965509101.SGD","LU2089984988.USD","BIB","LU1066053197.SGD","BK4578","BK4139","GILD","LU0109394709.USD","LU1037948897.HKD","IE00B3T34201.USD","BK4585","LU0058720904.USD","LU2357627491.SGD","LU2468319806.SGD","TMED","LU0114720955.EUR","SG9999015952.SGD","LU1061106388.HKD","LU0965508806.USD","LU1037948541.HKD","LU0965509010.AUD","BK4588","SG9999015986.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","MEDI","BBH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667237756","title":"Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667237756","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667237756?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMED","LU2089984988.USD","LU1934455277.USD","BK4568","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4566","LU1778281490.HKD","LU1057294990.SGD","LU0859254822.USD","BK4550","LU0965508806.USD","LU0965509283.SGD","LU1061106388.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","BK4583","LU0289739699.SGD","LU0882574055.USD","LU0965509101.SGD","BK4585","LU0058720904.USD","LU1674673428.USD","IE00BKVL7J92.USD","BIB","TMED","SG9999015945.SGD","GILD","LU1037948541.HKD","SG9999015978.USD","LU1674673691.USD","BK4532","IBB","LU2468319806.SGD","BK4578","SG9999015952.SGD","TBXU","BK4588","BBH","LU1585245621.USD","LU0861579265.USD","LU1839511570.USD","LU1934455194.USD","MEDI","IBBQ","LU2357627491.SGD","IE00B19Z3581.USD","SG9999015986.USD","IE0002270589.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230916","title":"Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230916?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":"Gilead, PAHO agree on HIV prevention drug access in Latin America, CaribbeanSept 15 (Reuters)-U.S. drugmaker Gilead SciencesGILD.Osaid on Tuesday it had reached an agreement with the Pan American Heal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1037948541.HKD","LU0823416689.USD","SG9999015978.USD","LU0889565916.HKD","BK4578","SG9999015945.SGD","LU0122379950.USD","SG9999015986.USD","LU2112291526.USD","LU1839511570.USD","BK4568","LU1778281490.HKD","LU2089984988.USD","IE00BKVL7J92.USD","LU0109394709.USD","BIB","BK4585","BMED","IE00BSNM7G36.USD","IE0002270589.USD","LU1674673428.USD","LU0965509010.AUD","TBXU","LU2357627491.SGD","LU2324357040.USD","LU1934455863.HKD","TMED","LU0320765992.SGD","IE00B7SZLL34.SGD","IBB","LU1066053197.SGD","LU1571399168.USD","LU1023059063.AUD","BK4532","BK4139","IE00B19Z3581.USD","LU0114720955.EUR","LU1037948897.HKD","LU1430594728.SGD","LU1674673691.USD","IBBQ","LU0289739699.SGD","BBH","MEDI","BK4583","BK4566","GILD","LU0234570918.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230686","title":"Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230686","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMED","IE00B7SZLL34.SGD","LU1430594728.SGD","BK4568","LU1571399168.USD","LU1778281490.HKD","IE0002270589.USD","LU1934455863.HKD","LU0234570918.USD","LU0861579265.USD","LU1037948541.HKD","LU2089984988.USD","GILD","BMED","BK4585","LU0289739699.SGD","TBXU","BK4578","LU0859254822.USD","BK4588","IBB","SG9999015945.SGD","LU2468319806.SGD","LU1839511570.USD","LU1061106388.HKD","LU1023059063.AUD","LU1585245621.USD","LU0058720904.USD","IE00B3T34201.USD","IBBQ","LU0965509101.SGD","BIB","LU1674673691.USD","BK4532","SG9999015986.USD","BBH","LU0965509283.SGD","LU1066051498.USD","LU0965509010.AUD","MEDI","LU2324357040.USD","BK4583","LU1066053197.SGD","LU1674673428.USD","SG9999015952.SGD","BK4550","LU0114720955.EUR","LU0882574055.USD","LU1037948897.HKD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462372","title":"Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462372?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU1037948541.HKD","LU1061106388.HKD","GILD","LU0114720955.EUR","IE00B19Z3581.USD","LU0889565916.HKD","TMED","LU0109394709.USD","LU0823416689.USD","LU0122379950.USD","LU0058720904.USD","BK4139","BBH","LU1585245621.USD","LU0882574055.USD","SG9999015945.SGD","IBB","LU1430594728.SGD","LU0965509101.SGD","BK4578","BK4550","IE00BSNM7G36.USD","BK4568","LU0289739699.SGD","LU1674673691.USD","LU0965508806.USD","LU1023059063.AUD","LU1057294990.SGD","LU2357627491.SGD","IBBQ","LU1571399168.USD","LU1934455863.HKD","BMED","LU1934455277.USD","TBXU","LU0234570918.USD","MEDI","LU0965509010.AUD","BK4532","LU1934455194.USD","SG9999015978.USD","IE00B3T34201.USD","LU1674673428.USD","BIB","IE00B19Z3B42.SGD","LU2089984988.USD","LU0859254822.USD","IE00BZ1G4Q59.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642045","title":"Legend Biotech Taps Novartis Veteran Zhang as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642045","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642045?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:42","pubTimestamp":1789476175,"startTime":"0","endTime":"0","summary":"Legend Biotech taps Novartis veteran Zhang as CEOSept 15 (Reuters)-Legend BiotechLEGN.Oon Tuesday appointed longtime NovartisNOVN.Sexecutive Ingrid Zhang as its CEO, effective immediately, banking on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","PPH","LU0211331839.USD","IE00B2B36J28.USD","BK4007","BK4585","BK4578","IE00BJT1NW94.SGD","NVS","IE0002141913.USD","LU0320765489.SGD","MEMS","LU0070302665.USD","BK4532","BK4505","BK4139","IE0009355771.USD","CANC","MEDX","BK4588","IE00BJJMRZ35.SGD","MEDI","IE00B4R5TH58.HKD","LU0208291251.USD","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU0861579265.USD","LU1571399168.USD","LU1674673691.USD","SG9999015952.SGD","LU1430594728.SGD","IE00B7SZLL34.SGD","MEDI","IE00BSNM7G36.USD","LU1839511570.USD","IBBQ","TMED","LU1778281490.HKD","BK4583","IE00B19Z3B42.SGD","BBH","LU2468319806.SGD","TBXU","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1061106388.HKD","LU1066051498.USD","LU0320765992.SGD","IBB","LU1037948541.HKD","BK4578","LU2112291526.USD","LU0058720904.USD","SG9999015978.USD","IE00BKVL7J92.USD","BK4566","BMED","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1585245621.USD","LU1934455194.USD","LU0114720955.EUR","BIB","LU0859254822.USD","LU0889565916.HKD","LU0882574055.USD","BK4585","LU0965509010.AUD","BK4550","LU2089984988.USD","LU0122379950.USD","BK4139","BK4568","IE00B3T34201.USD","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","LU2357627491.SGD","LU1934455277.USD","LU1037948897.HKD","LU0289739699.SGD","LU2087621335.USD","LU1934455863.HKD","BK4532","LU2324357040.USD","LU0823416689.USD","IE0002270589.USD","GILD","SG9999015945.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693129","title":"NYSE Order Imbalance 99880.0 Shares on Sell Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693129","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693129?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:50","pubTimestamp":1789415403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nAQN2MJ6LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","LU0211331839.USD","PPH","MEDX","BK4585","BK4578","BK4588","LU0070302665.USD","NVS","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","IE0002141913.USD","BK4007","LU0320765489.SGD","LU0208291251.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667187","title":"Novartis AG Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667187","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667187?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:15","pubTimestamp":1789402500,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  advanced 1.7% to CHF113.92 Monday on what proved to be an overall positive trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.7% to 13,878.54.Novartis AG closed CHF18.76 below its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 3,025,084, compared to the 50-day average trading volume of 2,517,640.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0070302665.USD","BK4007","PPH","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4585","LU0208291251.USD","BK4532","IE00B4R5TH58.HKD","BK4578","BK4588","LU0320765489.SGD","IE00BJJMRZ35.SGD","NVS","IE00B2B36J28.USD","IE0002141913.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","BK4534","LU1868836757.USD","LU2237443895.HKD","LU2324357040.USD","LU0203201768.USD","LU1145028129.USD","LLII","THNR","IE00BFSS7M15.SGD","LU2750360997.AUD","IE00B1XK9C88.USD","LU0106261372.USD","LU2756315664.SGD","LU0225283273.USD","PBE","BK4585","LU1868836591.USD","BBH","LU2746668974.SGD","AGNG","LU0823434740.USD","SG9999001440.SGD","SG9999015945.SGD","LU2468319806.SGD","JDOC","LU2111349929.HKD","LU2237443465.HKD","LU1291159041.SGD","BK4578","LU2471134952.CNY","NVS","LU2750360641.GBP","SG9999018857.SGD","LU0079474960.USD","ELIL","LU1548497426.USD","LU2168564495.EUR","LU1023059063.AUD","LU1057294990.SGD","LU2237443382.USD","LU0210536198.USD","LU1989771016.USD","LU1868837300.USD","LU2237443549.SGD","LU0466842654.USD","IE00B7KXQ091.USD","LU0943347566.SGD","LU0320765059.SGD","MEDX","LU0683600562.USD","LU2237443622.USD","LU2361044865.SGD","LU0316494557.USD","LU2063271972.USD","LU2552382215.SGD","LU0061475181.USD","LU0868494617.USD","LU1127390331.HKD","LU0471298694.HKD","LU0174119429.USD","LU1691799644.USD","LU0456855351.SGD","VHT","NVOX","LU0323591593.USD","LU2491049909.HKD","LU1061106388.HKD","SG9999014898.SGD","IE00BWXC8680.SGD","LU0353189680.USD","04332","LU0114720955.EUR","LU0385154629.USD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1551013342.USD","LU2456880835.USD","NVO","TMED","LU2360106947.USD","LU0708995401.HKD","LU2471134879.HKD","IE00BK4W5L77.USD","BK4139","LU2361045086.USD","LU2462157665.USD","LU0109391861.USD","LU2491050071.SGD","HRTS","LU1868836914.USD","LU1720051108.HKD","IE00BJLML261.HKD","SG9999018865.SGD","IE0005OL40V9.USD","LU2023250504.SGD","LU0354030511.USD","IHE","LU0345770993.USD","LU2106854487.HKD","SG9999001176.SGD","IBBQ","LU0432979614.USD","IE00BKDWB100.SGD","LU2089284900.SGD","BK4599","IE00B2B36J28.USD","IYH","LU0787776722.HKD","LU0882574139.USD","SG9999015978.USD","LU0208291251.USD","LU0256863902.USD","LU0320765489.SGD","LU0820561818.USD","BK4533","LU2461242641.AUD","LLYX","BIB","IE0004445239.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","LU2491050154.USD","SG9999014880.SGD","SG9999001176.USD","SG9999015952.SGD","LU0070302665.USD","LU2746668461.USD","LU1267930730.SGD","ILDR","XLV","LU1983299246.USD","LU2168564222.USD","BK4566","LU2213496289.HKD","IXJ","LU0689472784.USD","IE00BJJMRY28.SGD","LU1712237335.SGD","LU0109394709.USD","LU1804176565.USD","NVOH","LU0238689110.USD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0211331839.USD","LU0471298777.SGD","LU1093756325.SGD","CANC","LU1035775433.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2265009873.SGD","CURE","LU1093756168.USD","LU0006306889.USD","SGXZ57979304.SGD","LU2237443978.SGD","LU0786609619.USD","LU0198837287.USD","LU1917777945.USD","LU2357305700.SGD","SG9999013999.USD","LU2471134523.USD","TRUH","BK4588","RXL","LU1232071149.USD","LU2552382058.USD","PJP","LU0096364046.USD","LU2417539215.USD","LU2896262040.SGD","LU2211815571.USD","SG9999017495.SGD","LU1571399168.USD","LU0823434583.USD","LU1974910355.USD","IE00B4JS1V06.HKD","LU0133085943.USD","LU1988902786.USD","BK4581","MEDI","LU1280957306.USD","MHIP","LU2242652126.USD","IE00B1BXHZ80.USD","FHLC","LU2112291526.USD","IE00BFSS8Q28.SGD","PPH","SG9999014914.USD","LU0266013472.USD","LU0820562030.AUD","LU2471134796.USD","LU0417517546.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1979441026.SGD","LU2602419157.SGD","NVOC","LU0154236417.USD","LU0354030438.USD","LLYZ","AMGN","LU0964807845.USD","IE00BK4W5M84.HKD","LU0158827781.USD","LU1551013425.SGD","LU0889565916.HKD","LU2756315318.SGD","GB00BDT5M118.USD","LLY","LU2237438978.USD","OZEM","LU0823416689.USD","LU0058720904.USD","LU1868837136.USD","FTXH","LU0320765992.SGD","LU0820561909.HKD","GDOC","LU2271345857.HKD","LU0882574055.USD","SGXZ31699556.SGD","LU1069344957.HKD","LU2087625088.SGD","IE00BFTCPJ56.SGD","LU0158827948.USD","LU0345770308.USD","ELIS","IE0002141913.USD","LU2361044949.HKD","LU2462591350.SGD","IBB","LU0672654240.SGD","LU1323610961.USD","LU2023250330.USD","LU2552382132.HKD","LU0256863811.USD","LU0289739699.SGD","LU2108987350.USD","LU0094547139.USD","LU0234572021.USD","IE00BJT1NW94.SGD","IE00B775H168.HKD","LU1623119135.USD","LU2264538146.SGD","IE00BKPKM429.USD","LU1629891620.HKD","LU0353189763.USD","LU2168563687.JPY","WDNA","LU0097036916.USD","LU1366192091.USD","LU2168564149.EUR","LU2023251221.USD","IE00BJJMRX11.SGD","BK4007","IE0009355771.USD","LU0640476718.USD","LU2236285917.USD","SG9999014906.USD","TBXU","BK4532","LU0203202063.USD","LU2242646821.SGD","LU1814569148.SGD","IE0004445015.USD","LU1720051017.SGD","LU2028103732.USD","SGXZ81514606.USD","BK4516","LU2089984988.USD","SG9999015986.USD","IE00BN29S564.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666357738","title":"Novartis: More Pain on the Way?","url":"https://stock-news.laohu8.com/highlight/detail?id=2666357738","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666357738?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166520,"startTime":"0","endTime":"0","summary":"Can it get any worse for Novartis' U.S. stock?The Swiss company said Tuesday that del-desiran, part of a recent acquisition, reached the end of the line in a trial for a rare neuromuscular disease. Last week, another, pelacarsen, had failed to significantly reduce the risk of heart attacks and strokes. The drugmaker also halted trials of an experimental cell therapy earlier in September after three patient deaths.  The drugmaker's U.S.-listed shares slumped 13% to $139.01 Tuesday.These trials were crucial. Del-desiran was one of several late-stage therapies acquired through the $12 billion purchase of Avidity Biosciences. Novo has also been stung by falling sales of its big moneymaker, Entresto, which treats heart failure, and is faced with the expiration of patents.The drugmaker's hot dealmaking strategy?Traders believe it could sustain higher prices as the Iran war escalates. Diesel fuel, meanwhile, hit $6 a gallon for the first time in history. That could be felt, soon, up and down ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","BK4578","BK4588","MEDX","BK4585","LU0070302665.USD","LU0211331839.USD","IE00BJT1NW94.SGD","BK4532","BK4007","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE0009355771.USD","PPH","IE0002141913.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","LU0109394709.USD","LU0058720904.USD","LU0861579265.USD","BK4588","LU1674673691.USD","BMED","LU0114720955.EUR","MRNX","TBXU","LU1571399168.USD","LU1585245621.USD","BK4548","IBB","MEDI","LU1430594728.SGD","LU1934455277.USD","GILD","LU1674673428.USD","LU0965509101.SGD","IDNA","SG9999015986.USD","BK4578","IE00BKVL7J92.USD","IE00B19Z3581.USD","TMED","LU0289739699.SGD","LU2468319806.SGD","MRNA","SG9999015952.SGD","LU0889565916.HKD","LGHT","BBH","MRNY","BK4534","LU1778281490.HKD","IBBQ","LU1066051498.USD","GNOM","BK4139","LU2357627491.SGD","IE00B3T34201.USD","BIB","LU0965508806.USD","LU1057294990.SGD","LU0965509010.AUD","BK4568","SG9999015978.USD","LU0965509283.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":101,"code":"91000000","status":"200"}]}}